GE HealthCare Technologies Free cash flow decreased by 87.8% to $112.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $98.00M to $112.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 2.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $339.75M | $339.75M | $339.75M | $368.00M | -$78.00M | $548.00M | $986.00M | $325.00M | -$137.00M | $570.00M | $956.00M | $274.00M | -$183.00M | $652.00M | $811.00M | $98.00M | $8.00M | $483.00M | $916.00M | $112.00M |
| QoQ Change | — | +0.0% | +0.0% | +8.3% | -121.2% | +802.6% | +79.9% | -67.0% | -142.2% | +516.1% | +67.7% | -71.3% | -166.8% | +456.3% | +24.4% | -87.9% | -91.8% | >999% | +89.6% | -87.8% |
| YoY Change | — | — | — | — | -123.0% | +61.3% | +190.2% | -11.7% | -75.6% | +4.0% | -3.0% | -15.7% | -33.6% | +14.4% | -15.2% | -64.2% | +104.4% | -25.9% | +12.9% | +14.3% |